MARY FORD: Open Payments
NPI 1740808906 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,634 in 64 payments from 15 companies in 2025. Trend: 2023 $1,145 · 2024 $1,119 · 2025 $1,634
Food & beverage: $1,600Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $324 |
| CSL Behring | 12 | $282 |
| AstraZeneca Pharmaceuticals LP | 9 | $213 |
| Regeneron Healthcare Solutions, Inc. | 5 | $166 |
| Novartis Pharmaceuticals Corporation | 8 | $157 |
| Amgen Inc. | 3 | $81 |
| Pharming Healthcare, Inc. | 3 | $75 |
| Cycle Pharmaceuticals Inc | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| PFIZER INC. | 2 | $48 |
Products named: DUPIXENT, Andembry, Hizentra, AIRSUPRA, TEZSPIRE, RUCONEST, Sajazir, CUVITRU.
Industry payments across SC — which companies pay providers there.
